Rhian M Touyz Selected Research

Rhian M Touyz Research Topics

Disease

147	Hypertension (High Blood Pressure) 01/2022 - 01/2002
48	Inflammation (Inflammations) 01/2022 - 12/2002
30	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 06/2002
22	Vascular Remodeling 10/2021 - 01/2002
20	Fibrosis (Cirrhosis) 01/2022 - 06/2002
18	Stroke (Strokes) 03/2022 - 01/2002
17	Vascular System Injuries 01/2022 - 05/2003
15	Albuminuria 01/2022 - 06/2005
14	Neoplasms (Cancer) 01/2022 - 10/2009
14	Heart Failure 01/2021 - 06/2005
13	Diabetes Mellitus 12/2019 - 02/2004
12	Diabetic Nephropathies (Diabetic Nephropathy) 01/2022 - 06/2009
12	Body Weight (Weight, Body) 12/2018 - 08/2003
12	Hypertrophy 01/2017 - 05/2003
10	Myocardial Infarction 10/2021 - 06/2005
10	Obesity 12/2018 - 06/2003
9	Chronic Renal Insufficiency 01/2016 - 06/2005
7	Atherosclerosis 01/2021 - 05/2013
7	Cardiomegaly (Heart Hypertrophy) 01/2020 - 10/2003
7	Insulin Resistance 12/2018 - 06/2003
6	COVID-19 01/2022 - 01/2020
6	Vascular Diseases (Vascular Disease) 01/2020 - 03/2005
6	Hyperaldosteronism (Conn Syndrome) 01/2019 - 02/2005
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 02/2007
6	Isolated Systolic Hypertension 05/2010 - 06/2005
5	Pre-Eclampsia (Preeclampsia) 01/2022 - 05/2004
5	Cerebrovascular Disorders (Cerebrovascular Occlusion) 12/2019 - 05/2007
5	Type 2 Diabetes Mellitus (MODY) 12/2018 - 02/2004
5	Vascular Calcification 01/2018 - 02/2009
4	Chronic Disease (Chronic Diseases) 10/2022 - 02/2009
4	Thrombosis (Thrombus) 03/2021 - 01/2016
4	Hyperglycemia 09/2020 - 10/2009
4	Dyslipidemias (Dyslipidemia) 09/2020 - 06/2005
4	Necrosis 01/2020 - 10/2012
4	Magnesium Deficiency (Deficiency, Magnesium) 07/2011 - 05/2004
3	CADASIL 01/2021 - 11/2019
3	Cardiac Arrhythmias (Arrythmia) 01/2021 - 01/2020

Drug/Important Bio-Agent (IBA)

46	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 11/2002
38	Angiotensin IIIBA 01/2022 - 10/2002
25	NADPH Oxidases (NAD(P)H oxidase)IBA 01/2020 - 12/2002
24	SaltsIBA 01/2021 - 01/2002
21	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2002
19	MagnesiumIBA 10/2022 - 11/2002
17	AldosteroneIBA 01/2020 - 08/2002
15	AntioxidantsIBA 10/2021 - 01/2002
14	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2020 - 06/2005
13	Biomarkers (Surrogate Marker)IBA 03/2022 - 05/2012
13	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 05/2014
13	Phosphotransferases (Kinase)IBA 01/2021 - 11/2002
12	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2021 - 08/2003
11	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 02/2007
11	Angiotensin Receptor AntagonistsIBA 01/2020 - 06/2005
10	Endothelins (Endothelin)IBA 01/2022 - 01/2003
10	CollagenIBA 01/2022 - 06/2002
10	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 01/2021 - 06/2005
10	Endothelin-1 (Endothelin 1)IBA 01/2020 - 06/2002
9	Superoxides (Superoxide)IBA 01/2022 - 10/2003
9	Antihypertensive Agents (Antihypertensives)IBA 01/2021 - 06/2002
9	Protein Isoforms (Isoforms)IBA 10/2020 - 03/2009
9	LipidsIBA 12/2019 - 06/2005
9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 03/2019 - 06/2005
9	CholesterolIBA 10/2015 - 06/2005
8	Peptides (Polypeptides)IBA 01/2021 - 03/2005
8	1,4-dihydropyridine (dihydropyridine)IBA 05/2014 - 06/2005
7	rho-Associated KinasesIBA 03/2022 - 04/2003
7	Angiogenesis InhibitorsIBA 01/2022 - 01/2018
7	AngiotensinsIBA 10/2021 - 12/2002
7	ThiazidesIBA 01/2017 - 06/2005
7	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2014 - 06/2005
6	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2016 - 02/2008
6	Dietary SodiumIBA 02/2014 - 05/2007
6	Desoxycorticosterone Acetate (DOCA)FDA Link 04/2007 - 01/2003
5	Estrogens (Estrogen)FDA Link 01/2022 - 09/2009
5	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021 - 08/2004
5	Biological ProductsIBA 01/2020 - 10/2009
5	Vasoconstrictor AgentsIBA 01/2020 - 10/2004
5	CytokinesIBA 01/2020 - 05/2007
5	Streptozocin (Streptozotocin)FDA Link 10/2017 - 04/2014
5	DiureticsIBA 09/2013 - 05/2007
4	Acetylcholine (Acetylcholine Chloride)FDA Link 03/2022 - 02/2004
4	NADP (NADPH)IBA 01/2021 - 10/2005
4	Fibronectins (Fibronectin)IBA 01/2020 - 02/2012
4	MineralocorticoidsIBA 01/2020 - 10/2003
4	CationsIBA 01/2020 - 12/2010
4	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 12/2018 - 03/2009
4	AdipokinesIBA 08/2018 - 08/2014
4	Interleukin-6 (Interleukin 6)IBA 01/2017 - 12/2013
4	CalciumIBA 11/2016 - 02/2005
4	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 11/2016 - 05/2007
4	Spironolactone (Aldactone)FDA LinkGeneric 10/2015 - 07/2003
4	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 04/2015 - 02/2009
4	Desoxycorticosterone (Deoxycorticosterone)IBA 04/2007 - 10/2003
3	Oxygen (Dioxygen)IBA 01/2022 - 04/2006
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 06/2005
3	Pharmaceutical PreparationsIBA 12/2021 - 10/2016
3	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 04/2003
3	fasudil (AT 877)IBA 01/2021 - 01/2018
3	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2021 - 03/2011
3	Oxidoreductases (Dehydrogenase)IBA 01/2021 - 10/2011

Therapy/Procedure

37	Therapeutics 12/2021 - 05/2003